Skip to content

Welcome to Discover Pharma! Today is : November 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Advanced Therapies

  • Advanced Therapies,Clinical & Regulatory,Therapeutic Areas

    Ethris part of EU consortium to advance novel pandemic influenza vaccine

    Munich-based Ethris GmbH is part of a seven-organisation European consortium [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    Molecular Partners signs development agreement with Eckert & Ziegler for targeted alpha Radio-DARPin therapeutics

    Molecular Partners AG, a clinical-stage biotech developing DARPin-based therapeutics, announced [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Genomics and sequencing,Therapeutic Areas

    Circio presents new in vivo data showing enhanced circVec-AAV gene expression in eye

    Circio Holding ASA, a biotechnology company developing circular RNA-based gene [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    Link Biologics appoints Niall Martin to board as TSG-6 pipeline advances towards clinic

    Link Biologics has appointed Niall Martin to its board as [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    etherna intratumoral mRNA/LNP platform advances toward IND studies in non-melanoma skin cancer

    etherna, a biotech company specialising in mRNA and lipid nanoparticle [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development

    MaxCyte launches 96-well electroporation platform for cell therapy discovery

    MaxCyte, Inc. has launched ExPERT DTx, a 96-well electroporation platform [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Almirall meets guidance with 12.4% net sales growth and dermatology portfolio progress in 2025

    Almirall delivered net sales growth of 12.4% in 2025, surpassing [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics

    Abivax shows anti-fibrotic activity for obefazimod in IBD at ECCO 2026

    Abivax has presented new preclinical and clinical data for obefazimod [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas

    Hansa Biopharma’s BLA for imlifidase accepted by FDA

    Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain

    Lonza expands bioconjugate capabilities at Oss site to support ADC development

    Lonza expands its Advanced Synthesis capabilities at Oss, integrating ADC [...]

    May 5, 2026
Previous8910Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ViiV’s Cabenuva achieves superior viral suppression in CROWN Phase 3b study
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Shift Bioscience publishes AI virtual cell framework for target discovery
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
  • Aravax to present Phase 2 peanut allergy data in November
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top